1. U.S. Food and Drug Administration (FDA).Rare diseases: natural history studies for drug development (draft guidance for industry).https://www.fda.gov/media/122425/download. Published March 1 2019. Accessed April 15 2020.
2. Orphan drug development: the increasing role of clinical pharmacology
3. U.S. Food and Drug Administration (FDA).Rare disease cures accelerator to support innovation and quality in rare disease drug development.https://www.fda.gov/drugs/regulatory‐science‐research‐and‐education/rare‐disease‐cures‐accelerator. Published May 16 2022. Accessed May 16 2022.
4. U.S. Food and Drug Administration (FDA).Search Orphan Drug Designations and Approvals.https://www.accessdata.fda.gov/scripts/opdlisting/oopd/. Accessed March 2 2022.
5. U.S. Food and Drug Administration (FDA).CDER conversation: model informed drug development.https://www.fda.gov/drugs/news‐events‐human‐drugs/cder‐conversation‐model‐informed‐drug‐development. Accessed June 12 2018.